Most cyanobacteria (blue-green algae) can produce the neurotoxin b-N-methylamino-L-alanine (BMAA). Dietary exposure to BMAA has been suggested to be involved in the etiology of the neurodegenerative disease amyotrophic lateral sclerosis/ Parkinsonism-dementia complex (ALS/PDC). Little is known about BMAA-induced neurotoxicity following neonatal administration. Our previous studies have revealed an uptake of BMAA in the hippocampus and striatum of neonatal mice. Furthermore, rats treated with BMAA during the neonatal period displayed acute but transient motoric disturbances and failed to show habituation at juvenile age suggesting impairments in learning functions. In the present study, the aim was to investigate long-term behavioral effects of BMAA administration in neonatal rats. BMAA was administered on postnatal days 9-10 (200 or 600 mg/kg; subcutaneous injection). Spatial learning and memory was investigated in adulthood using the radial arm maze test. The results revealed impaired learning but not memory in BMAA-treated animals. The observed impairments were not due to alterations in motoric capacity, general activity, or behavioral profiles, as assessed in the multivariate concentric square field (MCSF) and open field tests. An aversive stimulus in the MCSF test revealed impairments in avoidance learning and/or memory. There was no difference in basal serum corticosterone levels in BMAA-treated animals, indicating that the observed long-term effects were not secondary to an altered basal hypothalamic-pituitary-adrenal axis function. The present data demonstrated long-term learning impairments following neonatal BMAA administration. Further studies on biochemical effects in various brain regions and subsequent behavioral alterations are needed to elucidate the mechanisms of BMAA-induced developmental neurotoxicity.
Algal blooming by cyanobacteria (blue-green algae) is of increasing concern since it is promoted and favored by the current eutrophication of aquatic environments (e.g., increased levels of nitrogen and phosphorus) and global warming (Paerl, 2008; Paul, 2008) . Recent studies have indicated that most cyanobacteria can produce the neurotoxic nonprotein amino acid b-N-methylamino-L-alanine (BMAA) (Banack et al., 2007; Cox et al., 2005) . Cyanobacteria are ubiquitous and capable of massive increases in numbers (algal blooming) in fresh, brackish, and marine waters all over the world. Moreover, BMAA has been detected in several water systems (Esterhuizen and Downing, 2008; Metcalf et al., 2008) and like other cyanobacterial toxins may accumulate in aquatic food chains (Falconer et al., 1992; Zimba et al., 2001) . This toxin has also been detected in the brains of North American Alzheimer's disease and amyotrophic lateral sclerosis (ALS) patients (Murch, Cox, Banack, Steele, and Sacks, 2004; Pablo et al., 2009) , but the results in previous studies are not consistent (Montine et al., 2005; Snyder et al., 2009) .
Dietary exposure to BMAA has been suggested to be involved in the etiology of a particular neurodegenerative disease (ALS/Parkinsonism-dementia complex; ALS/PDC) on the island of Guam (Banack and Cox, 2003; Spencer et al., 1987) . The neurotoxin has been detected in the brain tissue of ALS/PDC patients and also appears to accumulate in bats, which are part of a terrestrial human food chain on the island (Banack and Cox, 2003; Murch, Cox, Banack, Steele, and Sacks, 2004) . However, the role of BMAA in ALS/PDC is controversial (Cruz-Aguado et al., 2006; Steele and McGeer, 2008) . We have reported that BMAA interacts with the pigment melanin in the brain and the eye, which could link ALS/PDC to the uncommon pigmentary retinopathy seen in more than 50% of the patients (Karlsson, Berg, et al., 2009) .
Our previous studies have revealed poor blood-brain barrier (BBB) transfer of BMAA in adult mice and no specific localization in discrete regions of the brain (Karlsson, Berg, et al., 2009) . In contrast, high placental transfer of BMAA was observed on gestational day 14, with pronounced uptake by the fetal mouse brain. Furthermore, in neonatal mice, BMAA was also found to be transferred across the BBB, and there was distinct localization in specific areas of the brain such as the hippocampus and striatum . The brain growth spurt (BGS) is an important stage in the development of the central nervous system (CNS) and lasts for the first 3-4 weeks after birth in rodents (Dobbing and Sands, 1979) . The corresponding period in humans starts during the last trimester of pregnancy and continues until at least 2 years after birth (Dobbing and Sands, 1979) . The BGS is characterized by rapid neurodevelopmental changes such as axonal and dendritic growth, establishment of neuronal connections, synaptogenesis, and proliferation of glial cells followed by myelination (Davison and Dobbing, 1968) . The BGS is a sensitive period with respect to exposure to various xenobiotics, and disturbance of the processes can manifest as permanent changes in adults (Eriksson, 1997 (Eriksson, , 2000 Viberg et al., 2003) .
Our knowledge of the effects of developmental exposure to BMAA is limited. A previous report in which BMAA (500 mg/ kg) was administered on postnatal day (PND) 2 and PND 5 showed no major short-or long-term behavioral effects on rats (Dawson et al., 1998) . In contrast, our studies demonstrated that BMAA treatment of neonatal rats during the peak of BGS (PNDs 9-10) induced acute alterations such as impaired motoric capacity and hyperactivity . Furthermore, neonatal rats given a high dose of BMAA (600 mg/kg) failed to habituate to the test environment at juvenile age, suggesting that this substance may have effects on various cognitive functions . The aim of this study was to investigate the long-term effects of neonatal BMAA exposure in adult rats. In particular, we focused on behavioral profiles, anxiety-like behavior, learning, and memory mechanisms.
MATERIALS AND METHODS
Chemicals. Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich Co. (St Louis, MO).
Animals and Housing. Nine pregnant Wistar rats were obtained from Scanbur BK AB (Sollentuna, Sweden). Each dam was housed alone in a standard macrolon cage containing wood chip bedding and nesting material. The animals were maintained on standard pellet food (R36 Labfor; Lantmännen, Kimstad, Sweden) and water ad libitum and were housed in a temperaturecontrolled (22 ± 0.7°C) and humidity-controlled (55 ± 7%) environment on a 12-h light/dark cycle with lights on at 6:00 A.M. The animals were housed under a reversed 12-h light/dark cycle (lights off at 7:00 A.M.) after PND 31.
All animal experiments were approved by the Uppsala animal ethical committee and followed the guidelines of Swedish legislation on animal experimentation (Animal Welfare Act SFS1998:56) and European Union legislation (Convention ETS123 and Directive 86/609/EEC).
Experimental
Design. An outline of the experimental design is given in Figure 1 . A cross-fostering approach was used in this study as in the study by Dawson et al. (1998) . The litters were cross-fostered on the day of birth (PND 0). The cross-fostering procedure meant that all pups were randomly and evenly redistributed into seven new litters. Each new litter contained eight pups, with a homogeneous distribution of males and females as far as possible. Two litters were assigned to the control group and the low-dose group, respectively, and three litters to the high-dose group (each treatment group contained pups from 4 to 5 dams). The male pups were given one daily subcutaneous injection in the neck (20 ll/g) of BMAA at 200 mg/kg (n ¼ 8) or 600 mg/kg (n ¼ 11) freshly dissolved in Hanks' balanced salt solution, or vehicle (n ¼ 8), for 2 days during the peak of the BGS (PNDs 9-10). Four pups, from three different litters, in the high-dose group showed severe acute motor disturbance (emprosthotonic seizures or loss of righting reflex) hours after the second injection and were excluded . The body weight of each animal was monitored on PNDs 1, 4, 7, 9, [10] [11] [12] [13] [14] [15] [16] 19 , and 22 and in adulthood prior to each behavioral test. After weaning on PND 22 and onward, 2-4 male rats were housed together in standard macrolon cages (59 3 38 3 20 cm) in their respective treatment groups. The behavioral testing started in adulthood at 10 weeks of age, and all tests were performed during the dark phase of the cycle in order to study the animals during their active period. All arenas and apparatus used in the behavioral studies were wiped clean with 10% ethanol and allowed to dry between each animal. In adulthood, one of the control rats was excluded due to a methodological error. The acute and short-term effects of BMAA administration in these animals have been published elsewhere ).
The Multivariate Concentric Square Field Test. The multivariate concentric square field (MCSF) test has been described in detail elsewhere (Meyerson et al., 2006; Roman and Colombo, 2009) . The MCSF provides several areas for the animal to explore including sheltered, open, and elevated areas, a hole-board device, and areas with different illumination. The apparatus consists of a square field (100 3 100 cm) with a smaller square field (70 3 70 cm) located in the center. Openings in three of the walls of the center field lead to corridors that are connected to a dark corner room providing shelter to the animals, a hole-board device accessible by openings slightly elevated above the floor (hurdle), and a brightly illuminated wire mesh bridge construction (bridge) considered to be associated with risk. The following zones were further defined: central circle, a circular zone (22 cm in diameter) in the middle of the center, enabling distinguishing between center activity and thigmotaxis; slope, the slope leading up to the bridge, considered to be an area where the animal has to assess the risk of visiting the bridge; and bridge entrance, a zone at the start of the bridge. The animals were started in the center facing the wall without openings, and the test session lasted for 20 min. Dimmed light was used during the testing, except in the bridge area.
It has been shown previously that the animals acquire a memory of the MCSF arena, as assessed by the performance in a repeated trial (Meyerson et al., 2006; Roman and Colombo, 2009; Roman et al., 2007) . In the present study, a novel paradigm assessing avoidance learning was used. The strategy is similar to that of passive avoidance (Ehman and Moser, 2006) but also allows additional behavioral measures to be taken. The animals were tested twice: the first trial was performed when the rats were at the age of 10 weeks and the second trial 2 weeks later. After the 20-min session in the first trial, the scoring of the behavior was terminated and the animals were allowed to remain in the arena (20 min maximum allowed time) until they entered the bridge entrance. Upon return to the bridge entrance, the rats were subjected to an aversive air FIG. 1. Experimental design. The age of the animals at the time of BMAA administration and when the behavioral tests were conducted are indicated. The asterix (*) indicates that the acute and short-term effects of BMAA have been published separately 186 KARLSSON, ROMAN, AND BRITTEBO puff. The long-term effect of the air puff experience was then assessed in the repeated trial. This paradigm has been useful for evaluation of avoidance learning and memory, as rats exposed to an air puff avoid the bridge 2 weeks after the first trial; this is in contrast to animals that are allowed to visit the risk area without exposure to an air puff (Roman and Meyerson, 2009) . One of the animals in the high-dose group did not enter the bridge entrance in the first trial and was therefore excluded from the second trial. The behavioral parameters registered are explained in the Behavioral Recordings section.
The Elevated plus Maze Test. The elevated plus maze (EPM) test has been widely used to investigate anxiety-like behavior (Lister, 1990) . The maze used in this experiment has been described elsewhere (Roman et al., 2007) and has been used previously for assessment of the short-term effects of neonatal BMAA administration ). Rats 13 weeks of age were placed in the center of the EPM facing an open arm and were tested under dimmed light for 10 min. The defined zones of the EPM were the open and closed arms and the center portion, and the behavioral parameters registered are explained in the Behavioral Recordings section.
The Open Field Test. The open field (OF) test is a commonly used test for measurement of general exploration, ambulation, and emotional reactivity. The arena used in this study was as described elsewhere (Roman et al., 2007) with the exception that no start box was used. The arena was divided into zones, that is, a central circle 30 cm in diameter (the center) surrounded by a middle circle (width 15 cm), which was surrounded by an outer circle (width 15 cm). This setup has been used previously for assessment of the short-term effects of neonatal BMAA administration . The test was conducted, at 13 weeks of age, for 15 min under dimmed light to ensure locomotor activity, since the emotional component is more pronounced under bright light (Lister, 1990) . The behavioral parameters registered are explained in the Behavioral Recordings section.
The Radial Arm Maze Test. The radial arm maze (RAM) test is commonly used in studies of spatial learning and memory (Handelmann and Olton, 1981; Olton and Papas, 1979) . The apparatus used was an eight-arm radial maze in aluminum elevated 45 cm above the floor. Each arm (60 cm long and 12 cm wide) has low side walls and extends radially from a central platform (32 cm in diameter). The maze was located in a room with cues (e.g., table, door, and position taken by the experimenter), which enables the animal to navigate spatially in the maze. All eight arms were baited with a small piece of food pellet in a holder 2 cm outside each end, behind a low barrier, thus preventing the animals from seeing the food from a distance. The animals were tested at 20 weeks of age. They were habituated to the test environment for 1 day and then run for five consecutive days (acquisition) in order for them to learn the procedure. The long-term memory was then tested 2 weeks after the last acquisition trial (retention). At the start of the session, the rats were placed in the center facing north and the time (latency; seconds) until the first and all eight pellets were collected (eaten), total number of arms visited, and errors per animal (defined as reentries into arms in which the bait had already been collected) were scored. Errors per pellet collected were calculated to correct for group differences in pellets collected. An animal that entered a baited arm without consuming the food pellet was not scored as a correct response or an error but counted as a visit. Percentage of correct choices was calculated as number of pellets collected divided by the total number of visits. Animals that collected all pellets during the maximum allowed time 10 min passed the test. Rats that collected zero pellets were included in the analysis and given the maximum time 10 min. When calculating time (in seconds) per pellet collected, 10 min was used for animals that had not collected all pellets.
Restricted feeding was used to motivate the animals to search for food pellets in the RAM test (Handelmann and Olton, 1981; Olton and Papas, 1979) . Three days before the acquisition period and onward during the training, the rats were maintained on a daily 1-h feeding schedule, which was sufficient to keep body weight at 91-95% of the pretest weight. The same food restriction procedure was repeated 3 days prior to the retention test. There were no body weight differences between the groups, either during the acquisition period or at the time of the retention test.
Behavioral Recordings. The animals were monitored on a TV video setup in all tests except the RAM test. The RAM test was scored directly by an observer not blind to the treatment. Behavioral parameters in the MCSF, EPM, and OF tests were scored manually using Score 3.3 software (Pär Nyström; Copyright Soldis, Uppsala, Sweden) by an observer blind to the treatment. The time in seconds until the first visit to the defined zones (latency; LAT), number of visits (frequency; FRQ), duration (DUR) of the visits in seconds to the defined zones, and numbers of grooming, rearing, and number of animals visiting the defined zones or performing the scored behavior (occurrence) were registered. A visit to one of the defined zones was scored when both hind legs had crossed over into that section. The total number of visits to the defined zones (TOTACT) was registered in the MCSF, OF, and EPM tests. Also, in the EPM test, the total number of stretched attend postures (TOTSAP) and head dips (TOTDIP) were scored. The Ethovision system (version 2.3; Noldus Information Technology, Wageningen, The Netherlands) was used to record the distance moved (TOTDISTANCE; centimeters) in the MCSF and OF tests. The parameters TOTDISTANCE (MCSF and OF) and TOTACT (MCSF, EPM, and OF) were used as measures of general locomotor activity.
Corticosterone Analysis. The animals were sacrificed (between 9:30 A.M. and 3:00 P.M.) by decapitation at 23 weeks of age. Trunk blood was collected for analysis of basal corticosterone levels. The blood samples were centrifuged at 1000 3 g for 10 min. The serum was collected and stored at À80°C until analysis. The corticosterone analysis was performed using Coat-A-Count Rat Corticosterone 125 I RIA kit (Siemens Medical Solutions, Los Angeles, CA) following the instructions of the manufacturer. The intra-assay variability was 4.3%, and the interassay variation was 5.8%.
Statistical Analysis. The body weight of the animals showed a normal distribution and was analyzed using analysis of variance (ANOVA) and Fisher's protected least significant difference as post hoc test. The nonparametric Kruskal-Wallis test followed by the Mann-Whitney U-test was used for intergroup comparisons of behavioral parameters and corticosterone data. When animals did not enter a zone, the value was considered to be missing, except for the comparison of percentage of duration of visits to each zone. The chi-square test was used for analysis of occurrence. The distance moved over time in the OF and MCSF arena and measurements over time in the RAM test were analyzed using the nonparametric Friedman two-way ANOVA test and the Wilcoxon matched pairs test. Differences were considered statistically significant at P values < 0.05. Statistica 8.0 software (StatSoft Inc., Tulsa, OK) was used for the statistical analyses.
A multivariate projection-based approach, principal component analysis (PCA) (Eriksson et al., 2006) , was used to evaluate the MCSF data further. This method is designed to extract and display the systemic variation in a data set. The PCA has been shown to be a useful complement to traditional statistics in the analysis of behavioral parameters from the MCSF test (Meyerson et al., 2006; Roman and Colombo, 2009; Roman et al., 2007) . The results from the PCA are presented in a score plot and a loading plot. The score plot illustrates a summary of possible relationships between the individuals, and the loading plot identifies the variables important for these relationships. SIMCA-Pþ12 software (Umetrics AB, Umeå, Sweden) was used for the analysis.
RESULTS

Body Weight
A transient effect on body weight gain was noted in the group receiving BMAA at 600 mg/kg on PNDs 10-16 (Supplementary Figure) . At PND 19 and at weaning, no difference in body weight between the groups was found. The body weights at 10 weeks of age were 466 ± 13, 454 ± 10, and 468 ± 18 g for the control group, low-dose group, and the BMAA-INDUCED LONG-TERM COGNITIVE IMPAIRMENTS 187 high-dose group, respectively. There was no difference in average body weight between the groups at the time for any of the behavioral tests performed in adulthood.
The MCSF Test
The purpose of the multivariate design is to gather parameters into operational functional categories, which enables a behavioral profiling of the animals. The functional interpretation of the MCSF has been described in detail elsewhere (Roman and Colombo, 2009; Roman et al., 2006) . The first 20-min MCSF trial at 10 weeks of age did not show any differences with regard to general activity, exploration, risk assessment, risk-taking, or shelter-seeking behavior between the groups neonatally treated with BMAA or vehicle (Supplementary Table 2 ). Furthermore, all groups remained active over time, as revealed by a similar distance moved during the last 5 min as during the first 5 min of the 20-min trial (Fig. 2) . In agreement with the traditional statistics, the PCA score plot did not show a clear separation between the two BMAA treatment groups and controls. The loading plot shows the MCSF parameters included in the analysis (Fig. 3) .
The cognitive part of the test included an aversive stimulus at the bridge entrance at the end of the first MCSF trial. The long-term effect of this experience was assessed in a repeated trial 2 weeks later. Differences between groups were apparent. Eighty-three percent of the animals in the high-dose group and 63% of the animals in the low-dose group entered the bridge in trial 2, in comparison with 29% of the controls. In contrast to the BMAA-treated groups, the number of control rats that visited the bridge was significantly lower in trial 2 than in trial 1 (Fig. 4) . Thus, the consequence of the air puff in trial 1 assessed in trial 2 was more pronounced in the control group than in the BMAA-treated animals. There were no group differences in latency in entering the bridge entrance before the air puff was administered (Supplementary Table 2 ).
The intragroup differences in the second 20-min trial in the MCSF are given in Supplementary Table 3. A minor difference in exploratory activity was detected. An overall comparison showed differences between the groups in the number of rearings (H ¼ 6.73, p < 0.05). The rats that received the high dose of BMAA had a lower number of rearings than the control group and low-dose group (both p < 0.05). Parameters indicative of risk-taking behavior in the central circle showed differences between the groups. An overall comparison demonstrated a significant difference between groups in the number of visits (H ¼ 8.70, p < 0.05), duration (H ¼ 10.1, p < 0.01), and distance moved (H ¼ 9.10, p < 0.05) in the central circle. All parameters for the central circle were significantly lower in the rats that had received the high dose (all p < 0.01) as compared to the low dose, but not compared to the control rats. No differences in general activity or shelter-seeking behavior between the groups were observed for the total 20-min trial in trial 2.
In the second trial, minor differences between the groups in spontaneous activity over time, as measured by the distance moved in the arena, were detected. The controls travelled a significantly longer distance in the arena during the first 5 min in trial 2 compared to trial 1, in contrast to the BMAAtreated groups where no difference was detected (Fig. 2) . As a consequence of the longer distance moved during the first 5 min of the second trial in the control rats, the distance moved was significantly shorter during the last 5 min than the first 5 min in this group (Fig. 2) . In contrast, in the BMAA-treated groups, no difference in activity over time was detected. The low-dose BMAA group had significantly higher activity than the controls during the last 5 min of trial 2 (Fig. 2) .
The EPM Test
The results of the 10-min EPM trial at 13 weeks of age are given in Supplementary Table 4 arms than the other two groups (both p < 0.05). Furthermore, the animals in the high-dose group made significantly fewer stretched attend postures than those in the control group (p < 0.05). Both BMAA-treated groups made significantly more head dips than the control group (both p < 0.05). No other differences between the groups were detected.
FIG. 3. PCA based on behavior parameters from the first MCSF trial. (A)
The PCA score plot revealed no distinct separation of rats exposed to BMAA or vehicle during the neonatal period (PNDs 9-10) and tested at 10 weeks of age, indicating that there were no differences in explorative strategies and behavioral profiles between the groups. (B) PCA loading plot, illustrating the MCSF variables that were included in the analysis. Variables located further away from the origin are most important for the model. Vehicle control: n ¼ 7 animals; BMAA (200 mg/kg): n ¼ 8 animals; BMAA (600 mg/kg): n ¼ 7 animals.
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The OF Test
The results from the 15-min OF test at 13 weeks of age are shown in Supplementary Table 5 . An overall comparison revealed that there was no significant difference between BMAA-treated and vehicle-treated groups, in motoric capacity, locomotor activity, or for any other parameter measured, for example, thigmotaxis or center activity. All groups habituated to the test environment over time (data not shown).
The RAM Test
The results of the RAM test at 20 weeks of age are given in Table 1 and in Figures 5 and 6 . The 5-day acquisition period revealed significant differences between the groups. The animals in the control group passed the test (collecting all eight pellets) in 62% of the trials during the acquisition period as compared to 24% of the trials with the BMAA-treated groups (Fig. 5) . The BMAA-treated groups had lower percentage of correct choices on all days compared to the controls with significant differences on acquisition days 1 and 2 for the low-dose group and acquisition days 1, 2, and 5 and the retention trial for the high-dose group (Table 1) . The BMAA-treated rats collected less pellets than the control animals on all days with differences reaching statistical significance on acquisition days 1 and 3 (Fig. 6A) . On acquisition day 5, all groups collected significantly more pellets than on the corresponding day 1 (Fig. 6A) . The BMAA-treated groups did more errors per pellet collected compared to the control group, but the difference was only significant at acquisition day 1 for the group treated with the high dose of BMAA (Table 1) . The latency to first pellet collected decreased over the days in all groups during the acquisition period but was markedly longer in the BMAAtreated groups than in the control group, with a significant difference on day 5 (Fig. 6B) . On acquisition day 5, all groups had a shorter latency to the first pellet collected than on the corresponding day 1 (Fig. 6B) . The time spent per pellet collected was markedly higher in both groups of BMAAtreated animals than in the controls and reached significance on acquisition days 1-3 (Fig. 6C) . Thus, the session time differed between the groups and was significantly longer in the BMAA-treated groups than in the controls on acquisition day 2 (Fig. 6D) . On acquisition day 5, all groups spent less time per pellet collected than on the respective day 1 (Fig.  6C) . In contrast to the BMAA-treated groups, the control group had a significantly shorter session time and a reduced total number of visits on acquisition day 5 compared to the corresponding day 1 (Table 1 and Fig. 6D ).
FIG. 4.
The percentage of animals in each group that visited the risk area (bridge) in the first MCSF trial and in the repeated trial 2 weeks after the experience of a discomforting stimulus (air puff) at the entrance to the risk area in rats exposed to BMAA or vehicle during the neonatal period (PNDs 9-10 ). The animals were tested twice; they were exposed to the air puff at the age of 10 weeks, and the effect of the experience was assessed in the repeated trial 2 weeks later. Bars represent the percentage of animals that entered the bridge. **p < 0.01 compared with trial 1 (chi-square test). Vehicle control: n ¼ 7 animals; BMAA (200 mg/kg): n ¼ 8 animals; BMAA (600 mg/kg): n ¼ 6 animals. Note. Behavioral parameters recorded during the 10-min trial of the RAM test at 20 and 22 weeks of age in rats exposed to BMAA or vehicle during the neonatal period (PNDs 9-10). Passing test is defined as collecting all eight pellets. Errors per pellet collected were calculated to correct for group differences in pellets collected. Values represent mean ± SEM. *p < 0.05, **p < 0.01 compared to vehicle control animals, † p < 0.05 compared to 200 mg/kg (Kruskal-Wallis test and Mann-Whitney U-test or chi-square test); When compared to acquisition day 5, the retention test 2 weeks after the last acquisition day revealed no differences between the groups (Table 1 and Fig. 6 ), indicating that longterm memory was not affected in this test.
Corticosterone Analysis
There were no differences in basal corticosterone levels between the BMAA-treated groups and the vehicle-treated control group (Fig. 7) .
DISCUSSION
This study revealed long-term effects on performance of behavioral tasks in adult rodents treated with the cyanobacterial neurotoxin BMAA during the neonatal period. The most pronounced effects were the BMAA-induced impairments in spatial learning. Exposure to BMAA has been suggested to be involved in the etiology of the neurodegenerative disease ALS/ PDC. To our knowledge, this is the first report on long-term effects of BMAA on cognitive function in adult animals. The results of the behavioral tests indicate that the BMAA-induced impairments observed were not due to alterations in motoric capacity or general activity but to impaired spatial learning.
The temporal lobe, including the hippocampus, the entorhinal cortex, and the perirhinal cortex, is important for reference memory and working memory (Myhrer, 2003) . The   FIG. 5 . The percentage of trials passed (by definition collecting all eight pellets) during the acquisition period in the RAM test in rats exposed to BMAA or vehicle during the neonatal period (PNDs 9-10) and tested at 20 weeks of age. The animals in the control group passed the test in 62% of the trials while the animals exposed to BMAA (at 200 or 600 mg/kg) passed 24% of the trials. Bars represent percentage of trials passed by the animals. **p < 0.01, ***p < 0.001 compared with controls (chi-square test). Vehicle control: n ¼ 7 animals; BMAA (200 mg/kg): n ¼ 8 animals; BMAA (600 mg/kg): n ¼ 7 animals. 
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191 performance in spatial tasks, such as the RAM test, appears to be particularly sensitive to hippocampal dysfunction (Hodges, 1996) . Our previous studies have shown that there is distinct uptake of BMAA in the hippocampus of the neonatal rodent brain , and recent studies in adult mice have suggested that the hippocampus is the most BMAA-sensitive neuronal population in the brain (Buenz and Howe, 2007) . Furthermore, areas such as the prefrontal cortex, the amygdala, and the striatum are also important for several cognitive processes (Myhrer, 2003) . As previously demonstrated, the striatum is another area that has distinct uptake of BMAA in the neonatal rodent brain . This brain region has been suggested to have an impact on performance in the RAM test through its involvement in acquisition of response sequences (e.g., turning right or left) (Myhrer, 2003) . The present study revealed that BMAA-treated animals collected less pellets and displayed an impaired performance in general compared to controls, on all days during the acquisition period in the RAM test. The BMAAtreated groups had lower percentage of correct choices compared to the control group at all days. The latency to the first pellet collected and the time spent per pellet collected were markedly longer in both groups of BMAA-treated animals than with controls. It cannot be excluded that the observed treatment effects are related to a decreased food motivation. However, there was no difference in average body weight between the groups at any time during the test. These results are indicative of impaired spatial learning (Handelmann and Olton, 1981; Olton and Papas, 1979) in the BMAA-treated groups. The retention test performed 2 weeks after the last acquisition day revealed no differences in long-term memory between the groups. This suggests that the neonatal exposure to BMAA during the BGS period has long-term effects on spatial learning but not on long-term memory.
The multivariate design of the MCSF test allows investigation of general activity, exploration, risk assessment, risk-taking, and shelter-seeking behavior in one and the same test situation, thus enabling a behavioral profiling of the animal (Meyerson et al., 2006) . The results of the first 20-min trial in the MCSF showed that there were no differences in explorative strategies and behavioral profiles between the groups. The test paradigm, with an aversive stimulus administered at the bridge entrance in the MCSF test followed by assessment of the experience in a second trial, has been useful for evaluation of avoidance learning (Roman and Meyerson, 2009 ). This strategy is similar to that of passive avoidance, with the advantage of collection of additional behavioral parameters. It has been shown that rats exposed to an air puff had longer latency in visiting the zone prior to where the air puff was administered and avoided the bridge when tested 2 weeks after the first trial, in contrast to animals that were allowed to visit the risk area without exposure to an air puff (Roman and Meyerson, 2009) . In the present study, the repeated trial assessing the effects of an aversive stimulus (air puff) at the bridge entrance revealed an effect on performance in rats treated with BMAA during the BGS. Eighty-three percent and 63% of the animals in the high-and low-dose BMAA groups, respectively, entered the bridge in the repeated trial 2 weeks after the air puff experience, in comparison to 29% of the vehicle-treated controls. This finding provides evidence for an impaired association between the aversive stimulus and the spatial location. One limitation with the way the test was performed is that it is not possible to state whether the effects are due to impaired avoidance learning or memory and how the animals experience the air puff (i.e., more or less aversive). However, considering the evident impairments in spatial learning in the RAM test, the performance in the area associated with the aversive stimulus may reflect an effect on learning in the BMAA-treated groups. The second trial also demonstrated additional behavioral differences between the groups: in spontaneous activity over time. When the first and last 5-min periods were compared, the control group but none of the BMAA treatment groups lowered their spontaneous activity over time. This could be an effect of the aversive stimulus as the controls significantly increased their initial activity compared to trial 1. Altogether, the MCSF and the RAM tests demonstrated that there were impairments in learning mechanisms in adult rats that had been exposed to BMAA during the neonatal period.
The hypothalamic-pituitary-adrenal (HPA) axis is important for control of both emotional and cognitive processes. Longterm or chronic activation of the HPA axis can alter cognitive and emotional functions (de Kloet et al., 2008) . Furthermore, regulatory systems in the hippocampus exert inhibitory actions on the HPA axis through negative feedback regulation (Jacobson and Sapolsky, 1991) . The glutamatergic system also plays an important role in the regulation of the HPA axis. Systemic administration of glutamate agonists activates the HPA axis in neonatal and adult rodents (Kent et al., 1996; Zelena et al., 2005) . Considering the distinct uptake of BMAA in the hippocampus of the neonatal rodent brain shown previously long-term effects of environmental influences during the postnatal period on HPA axis activity (Pryce and Feldon, 2003) , it was of interest to investigate glucocorticoid secretion. Neonatal administration of BMAA might result in secondary effects on the HPA axis, with long-term consequences for learning and memory. The results revealed that there was no difference in basal serum corticosterone levels between animals treated with BMAA or vehicle, which suggests that the observed long-term effect of BMAA treatment during the BGS is not secondary to an altered basal HPA axis function. However, it cannot be ruled out that there are differences in stimulated corticosterone release between the groups.
Our previous study revealed that there were behavioral alterations in juvenile rats exposed to BMAA during the neonatal period. Juvenile rats that had received a high dose of BMAA neonatally spent significantly longer time and time per visit on the open arms in the EPM test than the juvenile rats exposed to a low dose or to vehicle alone . The results of the present EPM test in adult rats indicate that the animals in the high-dose BMAA group displayed less risk assessment behavior (less stretched attend postures, TOTSAP) and spent significantly longer time per visit on the open arms. Increased open arm activity is generally considered to be a characteristic of low anxiety-like behavior (Hogg, 1996; Lister, 1990) , which suggests that neonatal exposure to BMAA may result in long-term effects on emotional reactivity. In contrast to the observed effects in the EPM test, no differences between the groups were apparent in the OF test, another test with implications for emotional reactivity (Lister, 1990) , or in the MCSF test (Meyerson et al., 2006; Roman and Colombo, 2009) . Earlier studies using the MCSF test with the EPM as a reference test have demonstrated that the MCSF test is more sensitive than the EPM test in detecting changes in emotional reactivity (Roman and Colombo, 2009; Roman et al., 2006 Roman et al., , 2007 . Other interpretations of high open arm activity in the EPM test, such as an increased flight response, have been proposed (Holmes et al., 2000) . Furthermore, it cannot be ruled out that the altered cognitive function in BMAA-treated rats affected the behavior in the EPM test. No studies specifically designed to investigating the effects of BMAA on anxiety-like behavior have been reported, but they appear to be warranted.
We have previously reported an acute and dose-dependent hyperactivity in BMAA-treated pups together with impaired motoric capacity (e.g., unsteady gait and disturbed balance) in the group administered BMAA at 600 mg/kg. These effects were transient and no longer detectable in the OF test performed after weaning, suggesting that the animals had recovered over a short period of time . In accordance, the present OF and MCSF tests at adult age revealed no differences in motoric capacity or locomotor activity.
The mechanism underlying the BMAA-induced changes in behavior is not known. BMAA has been suggested to induce oxidative stress, to alter protein function through incorporation into proteins, and to induce neuronal degeneration via overactivation of glutamate receptors (Lobner et al., 2007; . BMAA has also been reported to affect neurite outgrowth and neurofilament protein levels at low concentrations (Abdulla and Campbell, 1993) . The findings presented here are in agreement with reports showing that neonatal exposure to high doses of glutamate during the BGS induces cognitive impairments in adult animals (Hlinak et al., 2005; Saari et al., 1990) . For instance, glutamate-treated animals were found to require a longer time to find and navigate to the platform in the Morris water maze, another test for assessment of spatial learning and memory (Saari et al., 1990) . The glutamatergic system is involved in the modulation of many of the events that occur during the BGS. Glutamate provides trophic functions in the developing brain by influencing synaptic plasticity, axonal and dendritic growth, and growth cone guidance, promoting proliferation and migration of neuronal cells (Ruediger and Bolz, 2007) . Neonatal exposure to the ionotropic and metabotropic glutamate receptor agonist BMAA (Copani et al., 1991; Lobner et al., 2007; Rao et al., 2006) could potentially disturb several of these processes, resulting in hypoplasia, neurons in the wrong location, abnormally oriented axons and dendrites, and abnormal synaptic connections-which could all lead to severe brain dysfunction. The time of exposure is also of major importance, since there is regional heterogeneity in the time course of developmental trajectories. This results in area-and system-specific periods of development and maturation (Andersen, 2003) . The granule cells in the dentate gyrus of the hippocampus are an example of neurons with exceptionally late time of origin and functional maturation. Approximately 85% of these neurons are generated after birth in rats, mainly during the first postnatal week (Bayer et al., 1993) . The developing brain also has significant potential for recovery of function. The present study, however, demonstrates that developmental exposure to BMAA results in permanent alteration of brain function and indicates that BMAA is a potential developmental neurotoxin. Possible sex-related differences in susceptibility to BMAA were not assessed since only male rodents were tested.
In conclusion, the results presented in this behavioral study demonstrate that exposure to BMAA during the critical period of CNS development, that is, the BGS, has long-term consequences for adult performance of behavioral tasks. The most evident support was detected in the RAM test, which revealed that the BMAA-treated animals had impairments in spatial learning. Alterations in line with the present results have been reported following neonatal exposure to glutamate, suggesting that the BMAA-induced changes seen may have been related to the glutamatergic system. Further studies on the biochemical effects of BMAA exposure in various brain regions during critical periods of nervous system development are, however, still needed in order to elucidate the mechanisms BMAA-INDUCED LONG-TERM COGNITIVE IMPAIRMENTS of BMAA-induced neurotoxicity and behavioral alterations in adult animals. The BGS in humans starts during the last trimester of pregnancy and last until at least 2 years of age. It is possible that the fetus may be exposed for BMAA indirectly in uterus via maternal exposure as demonstrated in our study in rodents or after birth from contaminated water or food. The actual degree of human exposure for BMAA is still unknown but the potential risk for human health cannot be neglected.
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